The study drug is a potential new treatment for chronic rhinosinusitis (sinus infections).

3 screening visits + 5 nights
1-3 visits

The study drug is a potential new treatment for chronic rhinosinusitis (sinus infections). It is hoped that this drug is more effective than current treatments, which often only give partial or temporary relief.

The study drug is administered via nasal irrigation (also called nasal rinse). It is a liquid that is passed through the sinuses by squeezing it into the nose with a squeeze bottle. You will be trained by our staff on how to perform a nasal irrigation.

Eligibility

Biological sex Male or Female
Age 18-55 years
BMI 18-32 kg/m2
Weight 50-120 kg
Medication Not taking any prescription medication (hormonal contraception is permitted)
Medical History No significant medical history
Asthma History No history of adult asthma is permitted
Allergies No history of hay fever or significant allergies